Stay updated with breaking news from ஜோ ஹோவர்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Home / Top News / Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE Study of Oxbryta ® (voxelotor) tablets in patients with sickle cell disease (SCD). The results showed significant and sustained improvement in hemoglobin levels, reduction in hemolysis and improved overall health status in patients treated with Oxbryta. These findings support th ....
Meet the Tameside foster families who have helped dozens of young people find a better future Each one is as different as the child they care for - can you join their ranks with Tameside Metropolitan Borough Council ? Advertorial Khalid and Rifat have fostered 28 children through Tameside There are many myths surrounding foster care which prevent some people from enquiring, but Tameside Council’s foster carers are here to share their experiences of how fostering changed their lives – and the lives of local children – for the better. Every child is different and there isn’t a one-size-fits-all mould for the ideal carer. Foster carers come with all different kinds of experience and from different backgrounds, and their uniqueness is often what makes them the perfect fit for the many different children in need of a loving home. ....